Search
Aclerastide
go.drugbank.com/drugs/DB12631InvestigationalAclerastide has been investigated for the treatment of Diabetic Foot, Diabetic Foot Ulcers, and Foot Ulcer, Diabetic.
Synonyms: 1-7-ANGIOTENSIN II, 3-L-NORLEUCINE-5-L-ISOLEUCINESafimaltib
go.drugbank.com/drugs/DB21528InvestigationalSafimaltib is a small molecule drug. Safimaltib is under investigation in clinical trial NCT06788509 (A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring).
Clesacostat
go.drugbank.com/drugs/DB18956InvestigationalClesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).
Neocartilage
go.drugbank.com/drugs/DB05257InvestigationalNeocartilage is generated from juvenile rather than adult chondrocytes. Neocartilage is the only scaffold-free living cartilage graft on the market.
DTx-1252
go.drugbank.com/drugs/DB18086ExperimentalDTx-1252 is a siRNA therapeutic under investigation for the treatment of Charcot-Marie-Tooth Disease type 1A (CMTD1A).[L48096]
NS-398
go.drugbank.com/drugs/DB14060ExperimentalNS-398 is a COX-2 inhibitor. It was developed as part of the mechanistic study of the cyclooxygenases.
Synonyms: N-(2-Cyclohexyloxy-4-nitrophenyl)methanesulfonamideCategories: Analgesics, Non-Narcotic, Anti-Inflammatory Agents, Non-SteroidalBiopterin
go.drugbank.com/drugs/DB03886ExperimentalA natural product that has been considered as a growth factor for some insects. [PubChem]
Actinium
go.drugbank.com/drugs/DB12860InvestigationalActinium has been investigated for the treatment of Breast Cancer and Pulmonary Disease, Chronic Obstructive.
Diethanolamine
go.drugbank.com/drugs/DB20489InvestigationalDiethanolamine is a small molecule drug. Diethanolamine is under investigation in clinical trial NCT02499549 (Two Treatment Regimens of Cocamide DEA Lotion for Head Lice).
Synonyms: N,n'-iminodiethanolTAK-754
go.drugbank.com/drugs/DB17850InvestigationalTAK-754 is an adeno-associated virus serotype 8 vector (AAV8) expressing B domain deleted codon optimized factor VIII. Developed by Takeda, it is being investigated for the treatment of hemophilia A.